In situ formulation of biomaterials for disease therapy: Recent advances in peptide assembly strategies

• Published in: Coordination chemistry reviews Vol. 523; p. 216251
• Main Authors: Xiong, Wenmin, Song, Na, Mo, Xiaowei, Zhang, Zeyu, Song, Jinyan, Wang, Yushi, Li, Junyu, Yu, Zhilin
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 15.01.2025
• Subjects: Biomaterials; Disease therapy; In situ assembly; Peptide assembly; Peptide assembly; Disease therapy; In situ assembly; Biomaterials
• ISSN: 0010-8545
• DOI: 10.1016/j.ccr.2024.216251

Biomaterials aim to address healthy issues and contribute to improve life quality for human beings. Currently available biomaterials have been challenged in performing theranostic objectives under real dynamic physiological conditions and at precise targeting sites. To address this concern, over the past few years in situ formulation of biomaterials has been developed to perform disease diagnosis and therapy in a precise manner involving different components. In this review, we introduced the concept of in situ-formed biomaterials and their design principles, specifically summarizing the progress of in situ-formed biomaterials based on stimulus-responsive self-assembly of peptides in living systems. We highlighted the recent examples of in situ assembling systems of peptides with applications ranging from cancer therapy, anti-inflammation and anti-bacteria, as well as tissue engineering and regeneration. The challenges met by in situ biomaterials and the prospects of in situ peptide assembly towards biomedicines are also discussed, which hopefully elucidates the great potential of in situ-formed biomaterials for future healthcare. [Display omitted] •Definition of in situ-formed biomaterials and their design principles are introduced.•Progress of in situ-formed biomaterials based on self-assembly of peptides is summarized.•Applications of in situ assembly of peptides with disease therapeutic efficacy is highlighted.•Potentials of in situ-assembled peptides for tissue engineering and regeneration is discussed.•The challenges and perspectives for in situ formulation of biomaterials based on peptide assembly are demonstrated.